Article Details
Retrieved on: 2025-10-15 15:26:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
First long-acting canine anti-nerve growth factor monoclonal antibody therapy administered once every three months · Approval marks major milestone in ...
Article found on: www.nasdaq.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here